piperacillin has been researched along with Bacterial Disease in 340 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 125 (36.76) | 18.7374 |
| 1990's | 92 (27.06) | 18.2507 |
| 2000's | 67 (19.71) | 29.6817 |
| 2010's | 52 (15.29) | 24.3611 |
| 2020's | 4 (1.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bradford, PA; Jones, CH; Mansour, TS; Petersen, PJ; Projan, SJ; Venkatesan, AM | 1 |
| Bradford, PA; Jones, CH; Petersen, PJ; Venkatesan, AM | 1 |
| Colchón, E; González-Bello, C; Pernas, M; Rodríguez, Á; Rodríguez, D | 1 |
| Chawla, K; Gupta, A; Kumar, A; Shenoy, PA | 1 |
| Dong, H; Gao, Y; Li, Q; Li, X; Liang, B; Mou, Y; Ren, L; Wang, D; Wang, L; Wang, S; Xiao, H; Xiu, W; Yang, K; Yin, Z; Yuwen, L; Zhang, Y | 1 |
| Carlier, M; De Cock, PAJG; de Jaeger, A; De Paepe, P; Delanghe, JR; Della Pasqua, OE; Robays, H; van Dijkman, SC; Vande Walle, J; Verstraete, AG; Willems, J | 1 |
| Chan, JD; Dellit, TH; Lynch, JB | 1 |
| Hahn, U; Lipman, J; Peake, SL; Roberts, JA; Roberts, MS; Sime, FB; Tiong, IS; Warner, MS | 1 |
| Buscher, H; Gentili, S; Imani, S; Marriott, D; Sandaradura, I | 1 |
| Hatti, M; Odenholt, I; Resman, F; Solomonidi, N; Tham, J | 1 |
| Ashhurst-Smith, C; Ferguson, JK; Hughes, C | 1 |
| Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X | 1 |
| Chiu, S; Ferguson, JK; Kozierowski, K; Munnoch, SA; Oldmeadow, C | 1 |
| Cabri, W; Cerisoli, L; Ferrazzano, L; Martelli, G; Ricci, A; Tolomelli, A; Viola, A | 1 |
| Brock, B; Friberg, LE; Kristoffersson, AN; Maarbjerg, SF; Nielsen, EI; Schrøder, H; Thorsted, A; Wang, M | 1 |
| Al-Shaer, MH; Alghamdi, WA; Graham, E; Peloquin, CA | 1 |
| Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ | 2 |
| Gupta, N; Rodrigues, C; Shetty, A; Soman, R | 1 |
| Damas, P; Frippiat, F; Lambermont, B; Vercheval, C | 1 |
| Charoenpong, L; Thamlikitkul, V; Tongsai, S | 1 |
| Leung, E; Ly, SC; Scheetz, MH; Venkatesan, N | 1 |
| Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A | 1 |
| Cies, JJ; Kuti, JL; Schlichting, C; Shankar, V | 1 |
| Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A | 1 |
| Arisoy, ES; Corapcioglu, F; Demirsoy, U; Karadogan, M; Karakurt, DG; Oncel, S | 1 |
| Jain, N; Tewari, VV | 1 |
| Han, S; Hong, T; Jeon, S; Lee, J; Paek, J; Woo, H; Yim, DS | 1 |
| Attivi, D; Gibaud, S | 1 |
| Boselli, E; Felton, TW; Hope, WW; Lodise, TP; Neely, MN; Roberts, JA; Van Guilder, M | 1 |
| Kishimoto, K; Kobayashi, K; Kobayashi, R; Sano, H; Suzuki, D; Yasuda, K | 1 |
| Chmura, A; Durlik, M; Kawecki, D; Lagiewska, B; Mlynarczyk, G; Pacholczyk, M; Sawicka-Grzelak, A | 1 |
| Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
| Chen, L; Wang, Y; Yang, H; Zhang, C; Zhou, Q | 1 |
| Pineda, LC; Watt, KM | 1 |
| Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S | 1 |
| Davies, SW; Dietch, ZC; Efird, JT; Guidry, CA; Sawyer, RG; Shah, PM; Willis, RN | 1 |
| Aamir, M; Abrol, P; Punia, H; Sharma, D | 1 |
| Gan, WJ; Mu, SM; Ran, XW; Shen, JF; Wang, J; Xian, Y; Xu, ZR; Yan, XD; Yuan, GY; Zhang, BS | 1 |
| Aduroja, OA; Amde, M; Connor, MJ; Fissell, WH; Gould, ER; Groszek, JJ; Madonia, PN; Nesbitt, R; Salem, C; Shotwell, MS; Taylor, ME; Tolwani, AJ; Wei, P | 1 |
| Foster, CB; Goldfarb, J; Gonzalez, BE; Sabella, C; Saracusa, C; Worley, S; Yusef, D | 1 |
| Gong, R; Huang, X; Li, C; Liu, J; Liu, Y; Xu, H | 1 |
| Alberg, T; Blix, HS; Eriksen, HM; Holen, Ø; Neteland, MI; Smith, I | 1 |
| Bassi, C; Benini, A; Bertazzoni Minelli, E; Franco, L; Pederzoli, P | 1 |
| Deshpande, MM | 1 |
| Esposito, S; Felaco, FM; Fiore, M; Ianniello, F; Leone, S; Noviello, S; Romagnoli, F; Sarli, E | 1 |
| Bleeker-Rovers, CP; Koopman, M; Mannaerts, L; Punt, CJ; van Herpen, CM | 1 |
| Hashimoto, Y; Uji, T | 1 |
| Erdem, E; Gulec, SG; Kebudi, R; Vural, S; Yildirmak, Y | 1 |
| Bayram, H; Dalay, C; Dalkiran, A; Saltoglu, N; Sert, M; Tasova, Y; Tetiker, T | 1 |
| Carmeli, Y; Jansen, JP; Kumar, R | 1 |
| An, MM; Chen, ML; Jiang, YY; Liu, P; Shen, H; Wang, R; Zhang, JD; Zou, Z | 1 |
| Dalley, AJ; Kirkpatrick, CM; Lipman, J; Roberts, JA; Roberts, MS | 1 |
| Blondiaux, N; Courcol, RJ; Durocher, A; Favory, R; Nseir, S; Onimus, T; Roussel-Delvallez, M; Wallet, F | 1 |
| Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N | 1 |
| Hayashi, Y; Lipman, J; Paterson, DL; Roberts, JA | 1 |
| Bansal, D; Gautam, V; Marwaha, N; Marwaha, RK; Oberoi, S; Sharma, RR | 1 |
| Ariga, T; Cho, Y; Ichikawa, M; Iguchi, A; Kaneda, M; Ohshima, J; Suzuki, D | 1 |
| Arakawa, S; Fujisawa, M; Matsumoto, T; Miura, T; Nakano, Y; Shigemura, K; Takahashi, S; Tanaka, K; Tsukamoto, T | 1 |
| Deman, H; Spriet, I; Verhaegen, J; Willems, L | 1 |
| Dwivedi, A; Gupta, SK; Pratyush, DD; Rai, M; Singh, SK; Tiwari, S | 1 |
| Farbman, L; Gafter-Gvili, A; Leibovici, L; Paul, M; Peck, A; Raanani, P; Ram, R; Shpilberg, O; Vidal, L; Yeshurun, M | 1 |
| Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F | 1 |
| Alder, J; Arvis, P; Dryden, M; Gyssens, IC; Kujath, P; Nathwani, D; Reimnitz, P; Schaper, NC | 1 |
| Berardi, B; Callea, A; Cormio, L; Fiorentino, N; Sblendorio, D; Traficante, A; Zizzi, V | 1 |
| Bornhauser, M; Ehninger, G; Hanel, M; Kroschinsky, F; Ordemann, R; Schuler, U; Wichmann, G | 1 |
| Friedland, I; Majumdar, A; Mixson, LA; Motyl, M; Woods, GL | 1 |
| Arakawa, S; Hayashi, Y; Iwai, S; Kamidono, S; Kumon, H; Matsumoto, T; Shinagawa, N; Takeyama, H; Tsukamoto, T; Yokoyama, T | 1 |
| Powell, LL; Wilson, SE | 1 |
| Gesser, R; McCarroll, K; Tellado, J; Teppler, H; Woods, GL | 1 |
| Esposito, S; Ianniello, F; Leone, S; Maiello, A; Marvaso, A; Noviello, S; Petronella, P | 1 |
| Mayumi, M; Takeuchi, M; Tanizawa, A | 1 |
| Charlett, A; Henwood, CJ; James, D; Johnson, AP; Livermore, DM; Mushtaq, S; Potz, N; Walker, RA; Warburton, F; Warner, M | 1 |
| Burroughs, A; Fisher, N; Hastings, M; Kibbler, C; Mutimer, D; O'Grady, J; Patch, D; Philpott-Howard, J; Rolando, N; Wade, J; Wendon, J | 1 |
| Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T | 1 |
| Meibohm, AR; Teppler, H; Woods, GL | 1 |
| Kwan, TH; Siu, YP; Tong, MK; Yung, CY | 1 |
| Gesser, RM; Graham, DR; Meibohm, AR; Roy, S; Solomkin, J; Teppler, H; Woods, GL | 1 |
| Friedland, IR; Gesser, RM; Herman, G; Isaacs, R; Meibohm, A; Mistry, G; Teppler, H; Woods, GL | 1 |
| Azanza, JR; Campanero, MA; García-Quetglas, E; Sádaba, B | 1 |
| Abe, T; Bradford, PA; Isoda, T; Mansour, TS; Mihira, A; Murphy, TM; O'Connell, J; Petersen, PJ; Projan, S; Takasake, T; Tardio, L; Ushirogochi, H; Venkatesan, AM; Weiss, WJ; Yang, Y | 1 |
| Boghossian, J; Caputo, W; Dana, A; Gray, S; Harkless, L; Pollak, R; Wu, D | 1 |
| Dzierzanowska, D; Dzierzanowska-Fangrat, K; Kurlenda, J; Małafiej, E; Puacz, E; Semczuk, K; Stalmaska-Dworak, E; Łopaciuk, U | 1 |
| Farga, A; Faus, F; Gimeno, C; Gómez, C; Goterris, R; Gutierrez, A; Martinez, F; Muñoz, I; Navarro, D; Solano, C | 1 |
| Bordigoni, P; Chastagner, P; Fouyssac, F; Mansuy, L; Salmon, A; Schmitt, C | 1 |
| Dana, A; Kuti, JL; Li, C; Mansfield, DL; Nicolau, DP; Nightingale, CH | 1 |
| Almassi, GH; Brown, KR; Edmiston, CE; Kehl, KS; Krepel, CJ; Lewis, BD; Loehrl, TA; Seabrook, GR; Smith, TL; Somberg, LB; Towne, JB | 1 |
| Gatti, M; Piscolla, F; Varoli, O | 1 |
| Jacobus, NV; Kuck, NA; Petersen, PJ; Tally, FP; Testa, RT; Weiss, WJ | 1 |
| Mullick, RN; Zissis, NP | 1 |
| Blum, M; Reers, B; Sulkowski, U; Winde, G | 1 |
| Amico, MC; Rampinelli, F; Tarantini, M; Tassi, P; Zanella, G | 1 |
| Houang, ET; Worth, R | 1 |
| Kuti, JL; Nicolau, DP; Ong, CT | 1 |
| Dana, A; DeRyke, CA; Kuti, JL; Mansfield, D; Nicolau, DP | 1 |
| Bhattacharya, SK; Kumari, N; Mohapatra, TM; Rai, A | 1 |
| Asperger, W; Chan, CY; Dela Pena, AS; DiNubile, MJ; Giezek, H; Kafka, R; Köckerling, F; Raz, R; Shivaprakash, M; Vrijens, F; Warren, B | 1 |
| Aslanzadeh, J; Brecher, S; Brossette, SE; Gavin, PJ; Gaydos, JM; Halstead, DC; Peterson, LR; Pierson, CL; Rotstein, C; Suseno, MT; Thomson, RB | 1 |
| Choudhri, S; Herrington, J; Malangoni, MA; Pertel, P; Song, J | 1 |
| Cafiero, F; Furfaro, E; Machetti, M; Majabo, MJ; Novelli, A; Solari, N; Viscoli, C | 1 |
| Burgess, DS; Frei, CR; Hampton, SL | 1 |
| Borbone, S; Cascone, C; Mezzatesta, ML; Santagati, M; Stefani, S | 1 |
| Ammann, RA; Bode, U; Engelhart, S; Fleischhack, G; Gröger, N; Hasan, C; Kramer, MH; Simon, A; Wilkesmann, A; Wiszniewsky, G | 1 |
| Antretter, H; Bonatti, H; Guggenbichler, JP; Ladurner, R; Laesser, R; Margreiter, R; Mark, W; Muehlmann, G; Stelzmueller, I; Tabarelli, D; Tabarelli, W; Wiesmayr, S; Zimmerhackl, LB | 1 |
| Abramson, MA; Jensen, EH; Namias, N; Solomkin, JS; Tomassini, JE | 1 |
| Abramson, MA; Armstrong, DG; Lipsky, BA; Polis, AB; Sheehan, P; Tice, AD | 1 |
| Hawkey, PM; Hsueh, PR | 1 |
| Abramson, MA; Hoey, CT; Lipsky, BA; Tice, AD; Turpin, RS; Wu, J | 1 |
| Cross, SE; Dalley, AJ; Lipman, J; Roberts, MS; Rudd, M; Venkatesh, B | 1 |
| Choudhri, S; Giordano, P; Lipsky, BA; Song, J | 1 |
| Bode, U; Fleischhack, G; Groll, AH; Laws, HJ; Lehrnbecher, T; Molitor, E; Simon, A; Tramsen, L; Wieland, R | 1 |
| Del Zompo, M; Fanos, V; Martinelli, V; Mussap, M; Stronati, M; Testa, M | 1 |
| Hamidah, A; Jamal, R; Nordiah, AJ; Rizal, AM | 1 |
| Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I | 1 |
| Rahman, M | 1 |
| Burdon, DW; Keighley, MR; Mojaddedi, ZJ; Morris, DL | 1 |
| Di Nola, F | 1 |
| Foerster, LA; Kohler, RB; Norton, J; Reynolds, J; Wheat, LJ; Williams, JM | 1 |
| Gale, RP; Hewitt, WL; Ho, WG; Winston, DJ; Young, LS | 1 |
| Beville, R; Holmes, B; Lutz, B; Mogabgab, W; Pollock, B | 1 |
| Klastersky, J | 1 |
| Aldridge, KE; Derks, F; Faro, S; Janney, A; Marier, RL; Sanders, CV; Williams, WW | 1 |
| Thieme, H; Tunn, UW | 1 |
| Fennelly, JJ; Kelly, DA | 1 |
| Wilkowske, CJ; Wright, AJ | 1 |
| Hadley, WK; Ohm-Smith, M; Robbie, MO; Sweet, RL | 1 |
| Asmar, BI; Bollinger, RO; Buckley, JA; Dajani, AS; Kauffman, RE; Thirumoorthi, MC | 1 |
| Hamaya, K; Hasegawa, Y; Makino, S; Masuda, K; Ninomiya, K; Yoshimoto, T | 1 |
| Braveny, I; Krüger, E; Machka, K | 1 |
| Komatsuda, M; Nagao, T; Nozaki, H; Yamauchi, K | 1 |
| Matsumoto, F; Ueda, Y | 1 |
| Bure, A; Decazes, JM; Laisne, MJ; Meulemans, A; Modai, J | 1 |
| McCloskey, RV; Trent, JA; Tutlane, VA | 1 |
| Weinstein, AJ | 1 |
| Pohlod, DJ; Saravolatz, LD | 1 |
| Braverman, S; Goldberg, M; Huang, NN; Keith, H; Palmer, J; Schidlow, D | 1 |
| Bowie, WR; Buskard, N; Chow, AW; Gribble, MJ; Grossman, L; Growe, GH; Naiman, SC; Plenderleith, LH; Sacks, SL; Smith, JA | 1 |
| Nelson, JD | 1 |
| Wittmann, DH | 1 |
| Lee, M; Ojeda, L; Sharifi, R | 1 |
| Dai, ZY; Gu, YM; Liu, YK; Tai, TY; Wang, F; Zhang, JD; Zhang, MF; Zhang, YY; Zhang, ZL | 1 |
| Kager, L; Nord, CE | 1 |
| Braveny, I; Dickert, H; Machka, K | 1 |
| Bach, VT; Rao, B; Thadepalli, H; White, D | 1 |
| Hewitt, WL; Murphy, W; Winston, DJ; Young, LS | 1 |
| Forbes, M; Kuck, NA; Testa, RT | 1 |
| Francke, EL; Neu, HC; Pancoast, S; Prince, AS | 1 |
| Macbeth, WA | 1 |
| Fortner, CL; Newman, KA; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH | 1 |
| Arimori, S; Komatsuda, M; Nagao, T; Nozaki, H; Yamauchi, K | 1 |
| Bidwell, JL; Bywater, MJ; Holt, HA; Reeves, DS | 1 |
| McAllister, TA | 1 |
| Aldridge, KE; Marier, RL; Marinaccio, AT; Mitchell, JW; Sanders, CV | 1 |
| Clark, BJ; Gooding, PG; Sathe, SS | 1 |
| Hikasa, Y; Kobayashi, N; Saito, T; Sekiya, T; Tanimura, H | 1 |
| Mandell, GL | 1 |
| Hikasa, Y; Huang, WF; Kobayashi, N; Sato, T; Sekiya, T; Takahashi, H; Tanimura, H; Yoshida, K | 1 |
| Barnes, RC; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ; Young, LS | 1 |
| Bodey, GP; Bolivar, R; Fainstein, V; Hay, M; Jadeja, L; Keating, M; McCredie, K | 1 |
| Douglas, GF; File, TM; Johnson, LA; Salstrom, SJ; Tan, JS | 1 |
| Azanza Perea, JR; Cuena Boy, R; Echeverría Echepare, LM; Honorato Pérez, J; Rubio González, A | 1 |
| Darrell, J; Placzek, M; Sahathevan, M; Want, S; Whitelaw, A | 1 |
| Stille, W | 1 |
| Ayers, LW; Barry, AL; Gavan, TL; Gerlach, EH; Jones, RN; Sommers, HM | 1 |
| Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH | 1 |
| Brogden, RN; Bryson, HM | 1 |
| Aldridge, KE | 1 |
| Kinzig, M; Sörgel, F | 1 |
| Lahnborg, G; Nord, CE | 1 |
| File, TM; Tan, JS | 2 |
| Grundel, E; Vestweber, KH | 1 |
| Brewster, SF; Gingell, JC; MacGowan, AP | 1 |
| Liu, CY; Lui, WY; Shyr, YM; Su, CH; Wang, LS | 1 |
| Dudley, MN | 1 |
| Jones, RN | 1 |
| Danziger, LH; Occhipinti, DJ; Rodvold, KA; Schoonover, LL | 1 |
| Havia, T; Huovinen, P; Klossner, J; Lehto, H; Niinikoski, J; Pekkala, E; Scheinin, H | 1 |
| Fujii, R; Fujita, K; Fukushima, N; Inyaku, F; Ishikawa, A; Okuno, A; Saijo, M; Takimoto, M; Wagatsuma, S; Yoshikawa, M | 1 |
| Lindsay, G; Stewart, M; Taylor, EW | 1 |
| Gorbach, SL | 1 |
| Nord, CE | 1 |
| Nowé, P | 1 |
| Bywater, MJ; Holt, HA; MacGowan, AP; Reeves, DS | 1 |
| Faro, S; O'Brien, WF; Roy, S; Sanfilippo, JS; Seidlin, M; Sweet, RL | 1 |
| Spencer, RC | 1 |
| Borowy, ZJ; Burul, CJ; Deitel, M; Fuksa, M; Krajden, S; Langer, JC; Rowan, J; Smith, LC; Wooster, DL; Yaman, M | 1 |
| Alhava, E; Haapiainen, R; Havia, T; Kivilaakso, E; Laitinen, S; Matikainen, M; Miettinen, P; Niinikoski, J; Pääkkönen, M | 1 |
| Cullmann, W; Elhardt, D; Tassler, H | 1 |
| Acar, JF; Goldstein, FW; Kitzis, MD | 1 |
| DeVries, VG; Kuye, O; Morrow, CA; Tally, FP; Teal, J | 1 |
| Eklund, AE; Nord, CE | 1 |
| Gentile, G; Girmenia, C; Martino, P; Meloni, G; Micozzi, A; Nucci, M; Venditti, M | 1 |
| Gupte, JM; Immermann, FW; Jacobus, NV; Testa, RT | 1 |
| Barie, PS; Cheadle, WG; Fink, MP; Garber, GE; Hebert, JC; Laverdiere, M; Polk, HC; Wilson, SE | 1 |
| Bauer, J; Klempa, I; Menzel, J; von Pritzbuer, E | 1 |
| Bourget, P; Carsin, H; Le Bever, H; Le Reveillé, R; Lesne-Hulin, A | 1 |
| Bourget, P; Ecoffey, C; Lesne-Hulin, A; Levaufre, B | 1 |
| Blumer, JL; Bonafede, ME | 1 |
| Chimura, T; Hirayama, T | 1 |
| Dvoretskiĭ, LI; Eremina, LV; Iakovlev, SV; Kaĭnov, MS; Koroleva, TA; Orlova, EA; Romanovskiĭ, IuIa; Shakhova, TV; Zhulin, SL | 1 |
| Iakovlev, SV | 1 |
| Chernen'kaia, TV; Lobakov, AI; Nasonov, VN; Rusanova, EV; Savitskaia, KI; Savov, AM; Silkina, TA | 1 |
| Higashitani, F; Hyodo, A; Kunugita, C; Nishida, K; Unemi, N | 1 |
| Carlisle, P; Cimino, M; Gucalp, R; Roberts, J; Rotstein, C; Yamamura, D | 1 |
| Donazzan, M; Ferri, F; Rose, C; Tellion, C | 1 |
| Altaras, M; Beyth, Y; Chowers, M; Fishman, A; Lang, R | 1 |
| Dudley, MN; Okereke, C | 1 |
| Betts, RF; Blair, EA; Flesher, WR; Griggs, JJ; Norton, JR; Rowe, JM | 1 |
| Asuka, T; Chiba, C; Kitazawa, J; Okamoto, T; Saito, T; Sato, Y; Takahashi, Y; Tateyama, N; Tsushima, T; Waga, S; Yokoyama, M | 1 |
| Ishihara, T; Nakamura, H; Tezuka, T; Toyonaga, Y | 1 |
| Iwai, N; Miyazu, M; Nakamura, H | 1 |
| Halbur, SR; Postelnick, M | 1 |
| Hayakawa, F; Itomi, K; Kato, T; Kuno, K; Miyajima, Y; Ogawa, A; Okumura, A; Takahashi, H | 1 |
| Ihara, T; Kamiya, H; Kitamura, K; Nishimori, H | 1 |
| Aida, K; Aramaki, M; Fukuda, T; Hayashi, M; Hoshuyama, A; Ikezawa, S; Imai, S; Kato, H; Matsuo, Y; Morita, J; Motohiro, T; Nagai, K; Oda, K; Oki, S; Sakata, Y; Takahgashi, K; Tananari, Y; Tsumura, N; Tsutsumi, T; Yamada, T; Yamakawa, R; Yamashita, Y; Yoshinaga, Y | 1 |
| Chan, YS; Chao, EK; Lee, SS; Shin, CH; Ueng, SW; Wang, CJ | 1 |
| Francis, L; Henry, RL; Jones, PD; Stuart, J | 1 |
| Bryce, EA; Frighetto, LO; Jewesson, PJ; Marra, CA; Marra, FO; Reynolds, RP; Sleigh, KM; Stiver, HG | 1 |
| Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R | 1 |
| Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P | 1 |
| Markham, A; Perry, CM | 1 |
| Cederberg, A; Forssell, H; Ohlin, B; Solhaug, JH; Tveit, E | 1 |
| Buchman, TG; Cheadle, WG; Cohn, SM; Haverstock, DC; Jungerwirth, S; Kowalsky, SF; Lipsett, PA; Milsom, JW; O'Marro, S; Rochefort, EV; Yellin, AE | 1 |
| Bolsoni, AP; Mendes, RE; Roland, RK; Sader, HS; Silbert, S | 1 |
| Christou, N; Eiseman, I; Siami, G; Tack, KJ | 1 |
| Daschner, F; Dietrich, ES; Ebner, W; Schubert, B | 1 |
| Niki, Y | 1 |
| Hidai, H | 1 |
| Bode, U; Fleischhack, G; Hasan, C; Havers, W; Marklein, G; Schmidt-Niemann, M; Wulff, B | 1 |
| Bucaneve, G; D'Antonio, D; Del Favero, A; Furno, P; Gentile, G; Mandelli, F; Martino, B; Martino, P; Menichetti, F; Micozzi, A; Ricci, P; Russo, D | 1 |
| Dubau, B; Frappier, S; Hernandez, V; Pédeboscq, S; Pometan, JP; Veyssières, D; Winnock, S | 1 |
| Androulakakis, E; Dimitriou, L; Kafetzis, DA; Lebesii, E; Maltezou, HC; Nikolaidis, P | 1 |
| Plosker, GL; Young, M | 1 |
| Liu, Y; Wang, R; Yu, B | 1 |
| Grant, EM; Kuti, JL; Nicolau, DP; Nightingale, C; Quintiliani, R | 1 |
| Schønning, K; Tvede, M | 1 |
| Spencer, RC; Wilcox, MH; Winstanley, TG | 1 |
| Brismar, B; Kasholm-Tengve, B; Nord, CE; Tunevall, G | 1 |
| Kelsey, SM; Newland, AC; Pocock, CE; Shaw, E; Weinhardt, B | 1 |
| Bäckstrand, B; Bergman, L; Brismar, B; Kihlström, E; Malmborg, AS; Mentzing, LO; Nyström, PO; Skau, T; Tunevall, G; Wretlind, B | 1 |
| Collins, PW; Kelsey, SM; Newland, AC; Weinhardt, B | 1 |
| Murase, T | 1 |
| Andremont, A; Boutan-Laroze, A; Culine, S; Droz, JP; Kattan, J; Ribrag, V | 1 |
| Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P | 1 |
| Hattori, M; Sampi, K | 1 |
| Bergmann, OJ; Dahl, M; Ellegaard, B; Ellegaard, J | 1 |
| Dubos, JP; Gremillet, C; Kacet, N; Lequien, P; Roussel-Delvallez, M; Storme, L | 1 |
| Ansari, A; Douglas, JG; Gould, IM; Harvey, G; Reid, TM; Smith, CC | 1 |
| Calandra, T; Gaya, H; Glauser, M; Klastersky, J; Meunier, F; Viscoli, C; Zinner, SH | 1 |
| Ahrne, H; Eilard, T; Eriksson, I; Lausen, I; Maller, R | 1 |
| Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O | 1 |
| Ikeda, K; Irino, S; Kubota, Y; Murata, M; Nagai, M; Ohnishi, H; Tanaka, T | 1 |
| Jacobus, NV; Petersen, PJ; Testa, RT; Weiss, WJ | 1 |
| Heizmann, WR; Manncke, K; Sonntag, HG; Springsklee, M | 1 |
| Bruckner, DA; Champlin, RE; Ho, WG; Winston, DJ | 1 |
| Bisetti, A; Grassi, L; Putti, P; Scacciacillani, E | 1 |
| Colette, C; Fromentin, C; Guerrier, T; Maillet, R; Roth, P; Schaal, JP | 1 |
| Cartañá, J; Cortés, J; Mascaró, M; Ruiz de Gopegui, RM; Yárnoz, MC | 1 |
| Boglino, C; Ciprandi, G; Cristini, S; Inserra, A; Serventi, P; Spagnoli, A | 1 |
| Averna, A; Mossuto, F; Romano, A | 1 |
| Amstutz, P; Blanloeil, Y; Cathala, B; Chopin, C; Gouin, F; Grimaud, D; Le Gall, JR; Rouby, JJ; Tempe, JD; Vanooteghem-Delbarre, A | 1 |
| Collins, PW; Delord, C; Kelsey, SM; Newland, AC; Weinhard, B | 1 |
| Jenkins, GC; Kelsey, SM; Newland, AC; Shaw, E; Wood, ME | 1 |
| Herva, E; Hovi, L; Lanning, M; Mäkipernaa, A; Perkkiö, M; Rajantie, J; Renkonen, OV; Ruuskanen, O; Salmi, T; Williams, K | 1 |
| Coleman, J; Doty, JE; Irving, C; Pitt, HA; Thompson, JE | 1 |
| Bonatti, PL; Destito, C; Venuto, V; Wiel Marin, A | 1 |
| Brisseau, JM; Feve, B; Grolleau, JY; Raffi, F; Reynaud, AE; Tiab, M | 1 |
| Hammerberg, O; Kurnitzki, C; Rosenbloom, D; Watts, J | 1 |
| Bordi, E; D'Amato, C; De Carlo, G; Puro, V; Visco, G | 1 |
| Jacobus, NV; Kuck, NA; Petersen, PJ; Testa, RT; Weiss, WJ | 1 |
| Kelsey, SM; Newland, AC; Shaw, E; Wood, ME | 1 |
| Heintz, AP; Mattie, H; Smit, I; Trimbos, JB; van Lindert, AC | 1 |
| Bawdon, RE; Heard, MC; Hemsell, DL; Hemsell, PG; Johnson, ER; Nobles, BJ | 1 |
| Anderson, H; Chan, CC; Oppenheim, BA; Scarffe, JH; Swindell, R | 1 |
| Bhamra, A; Brenner, MK; Hoffbrand, AV; Kibbler, CC; Mannan, P; Noone, P; Prentice, HG; Sage, RJ; Warner, P | 1 |
| Baglin, TP; Boughton, BJ; Brown, RM; Girling, AJ; Harris, RI; Jackson, N; Webberley, J | 1 |
| Agaliotis, D; Ezzeddine, H; Gala, JL; Gigi, J; Michaux, JL; Vandercam, B; Wauters, G | 1 |
| Dewar, EP; Lindsay, G; Taylor, EW; Walker, AJ | 1 |
| Acar, JF; Modaiï, J | 1 |
| Acar, JF; Ferre, B | 1 |
| Canton, P; May, T | 1 |
| Dubos, JP; Kacet, N; Lequien, P; Martin, GR; Roussel-Delvallez, M; Zaoui, C | 1 |
| Arlet, G; Leverger, G; Schaison, G | 1 |
| Beuscart, C; Mouton, Y; Soussy, C | 1 |
| Brice, P; Calvo, F; de Castro, H | 1 |
| Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
| Cesari, C; Cimino, M; Fenner, J; Rotstein, C; Winkey, K | 1 |
| Daschner, F | 1 |
| Bergerat, JP; Duclos, B; Dufour, P; Herbrecht, R; Lang, JM; Langs, JC; Oberling, F | 1 |
| Avvisati, G; Fenu, S; Girmena, C; Martino, P; Micozzi, A; Raccah, R; Santilli, S | 1 |
| Darrell, JH; Miall-Allen, VM; Whitelaw, AG | 1 |
| Busuttil, RW; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
| Bertino, E; Fabris, C; Licata, D; Roberi, P | 1 |
| Colucci, A; Coniglio, M; Girardi, F; Guarini, A; Iaculli, L; Liso, V; Pavone, V; Specchia, G | 1 |
| Godwin, PG; Millar, MR | 1 |
| Anaissie, EJ; Bodey, GP; Cabanillas, F; Elting, L; Fainstein, V; Kantarjian, H; McCredie, KB; Rolston, K | 1 |
| Heard, MC; Hemsell, DL; Hemsell, PG; Nobles, BJ | 1 |
| Doty, JE; Manchester, B; Mann, LL; Muller, EL; Pitt, HA; Thompson, JE | 1 |
| Carlisle, P; D'Olimpio, JT; McKitrick, JC; Miller, M; Sheridan, CA; Wiernik, PH; Wollner, DI | 1 |
| Ameglio, F; Casali, A; Gallo Curcio, C; Gionfra, T; Paoletti, G; Tonachella, R | 1 |
| Andrien, F; Anniko, M; Baudrihaye, M; Bow, E; Burman, LA; Louie, T; Norberg, B; Norrby, SR; Runde, V; Vandercam, B | 1 |
| Mangioni, C; Quadri, G; Regallo, M; Scalambrino, S; Turtulici, P | 1 |
| Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K | 2 |
| Chirova, L; Georgiev, D; Kenarova, B; Neitchev, C; Slavtcheva, E; Vassileva, B | 1 |
| De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW | 1 |
| Bartzokas, CA; Mackie, MJ; Purohit, S; Reilly, JT | 1 |
| Gunning, JE | 1 |
| Benigno, BB; Evrard, J; Faro, S; Ford, LC; LaCroix, G; Lawrence, WD; Ling, FW; McNeeley, SG; Nichols, DH; Sweet, RL | 1 |
| McCloskey, RV | 1 |
| Brendel, W; Hart, H; Seifert, J | 1 |
| Clavell, LA; González, M | 1 |
| Cunningham, FG | 1 |
| Cox, CE | 2 |
| Hata, T; Hojyo, Y; Koyasu, H; Kozaki, T; Nakamura, I; Nonoda, T; Watanabe, T | 1 |
| Johnson, JM; Saravolatz, LD; Suarez, AE; Wenokur, B | 1 |
| Newland, AC; Wood, ME | 1 |
| Braga, A; Mandelli, M; Mosconi, P; Rossi, A | 1 |
| Focht, J; Heilmann, HD; Heinrich, S; Klietmann, W | 1 |
| Childs, SJ; Mirelman, S; Wells, G | 1 |
| Beaucaire, G; Beuscart, C; Caillaux, M; Deboscker, Y; Fourrier, A; Mouton, Y | 1 |
| Baker, RJ; Donahue, PE; Finegold, SM; Johnson, WC; Middleton, JR; Monafo, WW; Wilson, SE | 1 |
| Donowitz, GR; Harman, C; Hess, CE; Scheld, M; Williams, ME | 1 |
| Cobbs, CG; Pierce, MA; Wofford, JD | 1 |
| Catovsky, D; Cohen, J; Darrell, JH; Donnelly, JP; Galton, DA; Goldman, JM; Marcus, RE; Want, SV; Worsley, AM | 1 |
| Levine, PA | 1 |
| Blumer, JL; Myers, CM; Reed, MD; Yamashita, TS | 1 |
| Ohtaguro, K; Sakagami, H; Ueda, K; Watanabe, H | 1 |
| Hattori, M; Kaneko, Y; Kumai, R; Sakurai, M; Sampi, K | 1 |
| Arione, R; Bramato, C; Capra, E; Chiavarino, M; Cimino, T; Di Nola, F; Eandi, M; Grosa, M; Salassa, B; Soranzo, ML | 1 |
| Forster, GE; Munday, PE | 1 |
| Holloway, WJ | 1 |
34 review(s) available for piperacillin and Bacterial Disease
| Article | Year |
|---|---|
β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Humans; Protein Structure, Secondary; Protein Structure, Tertiary; Treatment Outcome | 2020 |
Continuous infusion of piperacillin/tazobactam in patients with severe infections: A possible pharmacokinetic optimisation?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Drug Costs; Drug Stability; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2014 |
Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Databases, Factual; Humans; Odds Ratio; Penicillanic Acid; Piperacillin; Renal Insufficiency; Tachycardia; Tazobactam | 2015 |
New antibiotic dosing in infants.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Humans; Infant; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Meropenem; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Thienamycins | 2015 |
[Pharmacological properties and clinical efficacies of tazobactam/piperacillin (Zosyn 2.25, Zosyn 4.5), an injectable antibiotic combined with beta-lactamase inhibitor].
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Child; Clinical Trials as Topic; Drug Resistance, Bacterial; Humans; Injections, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2009 |
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome | 2009 |
Pharmacokinetic evaluation of piperacillin-tazobactam.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Treatment Outcome | 2010 |
Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; Carbapenems; Drug Administration Schedule; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome | 2013 |
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin | 2000 |
Safety and tolerability of ertapenem.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ceftriaxone; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic | 2004 |
[Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Male; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2005 |
[Current antibiotics series I: Piperacillin].
Topics: Adolescent; Adult; Animals; Bacterial Infections; Child; Child, Preschool; Dogs; Drug Hypersensitivity; Escherichia coli; Humans; Infant; Klebsiella; Mice; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Rats; Respiratory Tract Infections; Serratia; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Urinary Tract Infections; Vomiting | 1983 |
A perspective on new beta-lactam antibiotics in pediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Meningitis; Penicillins; Piperacillin | 1984 |
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam | 1994 |
Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
Topics: Abdominal Abscess; Bacteremia; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Peritonitis; Piperacillin; Surgical Wound Infection; Tazobactam; Virulence | 1994 |
Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections.
Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Metabolic Clearance Rate; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam; Tissue Distribution | 1994 |
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Ticarcillin | 1994 |
Combination beta-lactam and beta-lactamase-inhibitor therapy: pharmacokinetic and pharmacodynamic considerations.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1995 |
Clinical use of beta-lactamase inhibitors in combination with extended-spectrum penicillins.
Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Soft Tissue Infections; Tazobactam | 1995 |
Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 1995 |
Treatment of skin and soft-tissue infections.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Fasciitis; Humans; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases; Soft Tissue Infections; Surgical Wound Infection; Tazobactam | 1995 |
Piperacillin/tazobactam in the treatment of polymicrobial infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1994 |
The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam.
Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Combinations; Humans; Penicillanic Acid; Piperacillin; Tazobactam | 1994 |
Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Molecular Structure; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Ticarcillin | 1996 |
[A combined dosage form of piperacillin and tazobactam--tazocin].
Topics: Bacterial Infections; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1997 |
[Development of beta-lactamase inhibitors].
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Drug Therapy, Combination; Mice; Penicillanic Acid; Piperacillin; Tazobactam | 1997 |
Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Models, Biological; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam | 1998 |
Pharmacologic considerations with antimicrobials used in oncology.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Humans; Immunocompromised Host; Neoplasms; Opportunistic Infections; Piperacillin | 1998 |
Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
Topics: Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1999 |
[Fundamental and clinical studies on beta-lactamase inhibitors].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 2001 |
[Antibiotics--TAZ/PIPC, synercid, linezolid, everninomicin].
Topics: Acetamides; Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Linezolid; Oxazolidinones; Penicillanic Acid; Penicillins; Piperacillin; Protein Synthesis Inhibitors; Tazobactam; Virginiamycin | 2001 |
Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
Topics: Bacterial Infections; Cost-Benefit Analysis; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Economics, Pharmaceutical; Hospitalization; Humans; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2001 |
[Piperacillin/tazobactam--Tazocin. A penicillin-based alternative to 3rd generation cephalosporins and carbapenems].
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Penicillins; Piperacillin | 2002 |
Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapy.
Topics: Aminoglycosides; Ampicillin; Azlocillin; Aztreonam; Bacteria; Bacterial Infections; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Humans; Mezlocillin; Piperacillin; Pseudomonas aeruginosa; Thienamycins | 1986 |
140 trial(s) available for piperacillin and Bacterial Disease
| Article | Year |
|---|---|
Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients?
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cytokines; Female; Fever; Humans; Infant; Inflammation Mediators; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Risk Factors | 2014 |
Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; India; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Sepsis; Treatment Outcome | 2014 |
Comparison between piperacillin/tazobactam and cefepime monotherapies as an empirical therapy for febrile neutropenia in children with hematological and malignant disorders: A prospective, randomized study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Young Adult | 2015 |
A clinical evaluation of efficacy and safety of cefepime monotherapy versus piperacillin-tazobactam in patients of paediatric age group with febrile neutropenia in a tertiary care centre of north India.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Febrile Neutropenia; Female; Fever; Humans; India; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Tertiary Care Centers; Treatment Outcome | 2016 |
Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; China; Diabetic Foot; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Young Adult | 2016 |
Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2010 |
Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital.
Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetic Foot; Drug Combinations; Female; Hospitals, University; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Recurrence; Time Factors; Treatment Outcome | 2010 |
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult | 2010 |
Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2011 |
Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study.
Topics: Administration, Intravenous; Administration, Oral; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacterial Infections; Diabetic Foot; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Quinolines; Tazobactam; Treatment Outcome | 2013 |
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Injections, Intramuscular; Male; Penicillanic Acid; Penicillins; Piperacillin; Postoperative Complications; Prospective Studies; Prostatic Diseases; Tazobactam; Transurethral Resection of Prostate | 2002 |
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection | 2002 |
Piperacillin plus aztreonam for treatment of neutropenic fever.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillins; Piperacillin | 2003 |
Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae; Female; Fever; Humans; Liver Transplantation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prospective Studies; Staphylococcus aureus | 2003 |
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibility; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Treatment Outcome | 2004 |
Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Colonic Diseases; Demography; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Severity of Illness Index | 2004 |
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
Topics: Abdomen; Adolescent; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Treatment Outcome | 2004 |
An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sulbactam; Time Factors; Vancomycin; Wound Infection | 2005 |
Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin-tazobactam.
Topics: Adolescent; Adult; Aged; Amphotericin B; Bacteremia; Bacterial Infections; Female; Fever; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Matched-Pair Analysis; Middle Aged; Neutropenia; Penicillanic Acid; Peripheral Blood Stem Cell Transplantation; Piperacillin; Piperacillin, Tazobactam Drug Combination; Premedication; Transplantation, Autologous | 2005 |
Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam | 2005 |
Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection.
Topics: Abdomen; Adult; Bacterial Infections; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam | 2006 |
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Diarrhea; Ertapenem; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2006 |
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
Topics: Abdominal Abscess; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendicitis; Aza Compounds; Bacterial Infections; Cross Infection; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intestinal Perforation; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Quinolines; Safety; Stomach Rupture; Treatment Outcome | 2006 |
Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Bacteroides; beta-Lactams; Double-Blind Method; Ertapenem; Escherichia coli; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2007 |
Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Databases, Factual; Diabetic Foot; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Penicillanic Acid; Piperacillin; Quinolines; Tazobactam | 2007 |
Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2008 |
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
Topics: Bacterial Infections; Carbenicillin; Drug Therapy, Combination; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Penicillins; Piperacillin | 1982 |
Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Carbenicillin; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Penicillins; Piperacillin; Prospective Studies | 1982 |
Piperacillin v Carbenicillin in the therapy for serious infections.
Topics: Adult; Bacterial Infections; Carbenicillin; Drug Evaluation; Female; Humans; Liver Function Tests; Male; Microbial Sensitivity Tests; Penicillins; Piperacillin; Random Allocation | 1982 |
Evaluation of piperacillin sodium in the treatment of infections in immune compromised patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Female; Humans; Immunologic Deficiency Syndromes; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Penicillins; Piperacillin; Sepsis | 1982 |
Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections.
Topics: Adolescent; Adult; Bacterial Infections; Cefoxitin; Clinical Trials as Topic; Female; Genital Diseases, Female; Humans; Middle Aged; Penicillins; Piperacillin; Pregnancy | 1983 |
Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study.
Topics: Adolescent; Adult; Azlocillin; Bacterial Infections; Carbenicillin; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Penicillins; Piperacillin | 1983 |
Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Clinical Trials as Topic; Drug Therapy, Combination; Gentamicins; Humans; Penicillin Resistance; Piperacillin; Prospective Studies; Random Allocation; Ticarcillin; Tobramycin | 1983 |
A clinical evaluation of piperacillin in intra-abdominal infections.
Topics: Adult; Aged; Bacterial Infections; Cholangitis; Cholecystitis; Clinical Trials as Topic; Humans; Intestinal Diseases; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Piperacillin; Postoperative Complications; Premedication; Surgical Wound Infection | 1984 |
Comparative efficacy of piperacillin versus carbenicillin for complicated urinary tract infections.
Topics: Bacterial Infections; Carbenicillin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Recurrence; Urinary Tract Infections; Urologic Diseases | 1984 |
Laboratory and clinical studies of piperacillin.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Escherichia coli; Female; Humans; In Vitro Techniques; Infant; Infant, Newborn; Male; Middle Aged; Piperacillin; Respiratory Tract Infections | 1983 |
Clinical evaluation of piperacillin.
Topics: Adult; Aged; Bacterial Infections; Bacteroides; Clinical Trials as Topic; Female; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus | 1980 |
Clinical evaluation of piperacillin therapy for infection.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Child; Clinical Trials as Topic; Female; Humans; Lung Diseases; Male; Middle Aged; Penicillins; Piperacillin; Urinary Tract Infections | 1981 |
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Leukemia; Male; Middle Aged; Neoplasms; Penicillins; Piperacillin; Prospective Studies; Random Allocation; Ticarcillin | 1981 |
Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bacterial Infections; Clavulanic Acids; Drug Combinations; Female; Hallucinations; Humans; Male; Middle Aged; Moxalactam; Penicillins; Piperacillin; Sepsis; Ticarcillin | 1984 |
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin | 1982 |
Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
Topics: Abdomen; Abdominal Abscess; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam | 1994 |
Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; North America; Penicillanic Acid; Piperacillin; Tazobactam | 1994 |
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam.
Topics: Aged; Bacterial Infections; beta-Lactamases; Biopsy, Needle; Cefuroxime; Drug Therapy, Combination; Humans; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Prospective Studies; Prostate; Prostatic Neoplasms; Tazobactam | 1995 |
Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
Topics: Abdomen; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1995 |
Aspoxicillin versus piperacillin in severe abdominal infections--a comparative phase III study.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Bacterial Infections; Female; Humans; Male; Middle Aged; Piperacillin | 1994 |
[Comprehensive evaluation of pharmacokinetic and clinical studies on tazobactam/piperacillin in pediatric field].
Topics: Adolescent; Bacteria; Bacterial Infections; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Penicillanic Acid; Piperacillin; Tazobactam | 1995 |
Infection after colorectal surgery: a randomized trial of prophylaxis with piperacillin versus sulbactam/piperacillin. West of Scotland Surgical Infection Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anastomosis, Surgical; Bacterial Infections; Colon; Drug Therapy, Combination; Elective Surgical Procedures; Female; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Piperacillin; Premedication; Prospective Studies; Rectum; Scotland; Sulbactam; Surgical Wound Infection | 1995 |
Piperacillin/tazobactam in complicated urinary tract infections.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Recurrence; Remission Induction; Tazobactam; Urinary Tract Infections | 1994 |
Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Penicillanic Acid; Piperacillin; Tazobactam | 1994 |
Piperacillin versus cefazolin given perioperatively to high-risk patients who undergo open cholecystectomy: a double-blind, randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; Cefazolin; Cholecystectomy; Double-Blind Method; Female; Gallbladder; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Postoperative Complications; Premedication; Prospective Studies; Risk Factors; Surgical Wound Infection | 1993 |
Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Peritoneal Diseases; Piperacillin; Tazobactam; Treatment Outcome | 1993 |
Safety profile of piperacillin/tazobactam in phase I and III clinical studies.
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Penicillanic Acid; Piperacillin; Tazobactam | 1993 |
A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam | 1993 |
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Bacteria; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Teicoplanin | 1993 |
Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam.
Topics: Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1993 |
Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cholangitis; Cholecystitis; Clindamycin; Combined Modality Therapy; Diverticulitis; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam | 1993 |
[Perioperative use of ampicillin/sulbactam, cefoxitin and piperacillin/ metronidazole in elective colon and rectal surgery. A prospective randomized quality assurance study of 422 patients].
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cefoxitin; Colitis, Ulcerative; Colonic Polyps; Colorectal Neoplasms; Diverticulitis, Colonic; Drug Therapy, Combination; Elective Surgical Procedures; Female; Humans; Male; Metronidazole; Middle Aged; Piperacillin; Premedication; Prospective Studies; Quality Assurance, Health Care; Sulbactam; Surgical Wound Infection | 1993 |
Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection.
Topics: Adult; Bacterial Infections; beta-Lactamase Inhibitors; Burns; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam | 1996 |
Perioperative pharmacokinetics of piperacillin during liver transplantation.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacterial Infections; Carcinoma, Hepatocellular; Female; Half-Life; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Metabolic Clearance Rate; Middle Aged; Penicillins; Piperacillin; Prospective Studies | 1996 |
[Clinical study of tazobactam/piperacillin in obstetrics and gynecological infections].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Infusions, Intravenous; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1996 |
[Use of piperacillin/tazobactam as empirical monotherapy in the treatment of bacterial infections in a resuscitation department].
Topics: Adult; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Departments; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Resuscitation; Treatment Outcome | 1997 |
[Effect of piperacillin/tazobactam on the anti-infection resistance in patients with infections in the peritoneal cavity].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Drug Therapy, Combination; Humans; Immunity, Innate; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Peritoneal Diseases; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1997 |
Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients.
Topics: Adult; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin | 1997 |
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy.
Topics: Adult; Amphotericin B; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Piperacillin; Prospective Studies; Time Factors; Vancomycin | 1998 |
[Clinical studies of tazobactam/piperacillin (TAZ/PIPC) in pediatric patients].
Topics: Adolescent; Bacteria; Bacterial Infections; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1998 |
[Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].
Topics: Bacteria; Bacterial Infections; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1998 |
[Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].
Topics: Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1998 |
[Laboratory and clinical studies on tazobactam/piperacillin in the field of pediatrics].
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Child, Preschool; Drug Therapy, Combination; Escherichia coli; Female; Haemophilus; Haemophilus influenzae; Humans; Infant; Male; Penicillanic Acid; Penicillin Resistance; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae; Urinary Tract Infections | 1998 |
[Fundamental and clinical studies on tazobactam/piperacillin in the pediatric field].
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Child; Drug Therapy, Combination; Female; Humans; Infant; Male; Penicillanic Acid; Pharyngitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Respiratory Tract Infections; Staphylococcus aureus; Tonsillitis; Whooping Cough | 1998 |
[Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Topics: Acute Disease; Bacterial Infections; beta-Lactamase Inhibitors; Bordetella pertussis; Bronchitis; Child; Child, Preschool; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Infant; Lymphadenitis; Male; Otitis Media, Suppurative; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes; Urinary Tract Infections; Whooping Cough | 1998 |
Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; British Columbia; Cilastatin; Costs and Cost Analysis; Decision Trees; Double-Blind Method; Drug Therapy, Combination; Economics, Pharmaceutical; Enzyme Inhibitors; Female; Humans; Imipenem; Male; Models, Economic; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Protease Inhibitors; Statistics, Nonparametric; Tazobactam; Thienamycins; Treatment Outcome | 1999 |
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin | 1999 |
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin | 1999 |
Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Topics: Abdominal Abscess; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cefuroxime; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Intestinal Perforation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Rupture, Spontaneous; Surgical Wound Infection; Tazobactam | 1999 |
Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections.
Topics: Abdomen; Abdominal Abscess; Administration, Oral; Anti-Infective Agents; Appendicitis; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2000 |
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Skin Diseases, Infectious; Tazobactam | 2001 |
Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Gentamicins; Germany; Humans; Neoplasms; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Sulbactam; Tazobactam; Treatment Outcome | 2001 |
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2001 |
[Comparison of 2 administration protocols (continuous or discontinuous) of a time-dependent antibiotic, Tazocin].
Topics: Adolescent; Adult; Aged; Area Under Curve; Bacteria, Anaerobic; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2001 |
Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.
Topics: Abdominal Abscess; Adolescent; Appendicitis; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2001 |
[Multicentre clinical trial on efficacy and safety of domestic piperacillin/tazobactam for treatment of acute bacterial infections].
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Drug Therapy, Combination; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Skin Diseases; Tazobactam; Treatment Outcome | 2001 |
Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Chi-Square Distribution; Drug Therapy, Combination; Female; Hospitals, Community; Hospitals, Teaching; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Statistics, Nonparametric | 2002 |
Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; beta-Lactamase Inhibitors; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam | 1992 |
Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome | 1992 |
Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.
Topics: Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fever; Gentamicins; Glycopeptides; Humans; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Teicoplanin | 1992 |
[Aztreonam or gentamicin combined with piperacillin as empiric antibiotic therapy during neutropenia of patients with hematologic diseases].
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Aztreonam; Bacterial Infections; Cefamandole; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies | 1992 |
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin | 1992 |
[Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Piperacillin; Prospective Studies | 1992 |
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies | 1991 |
Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group.
Topics: Adult; Aged; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hearing; Humans; Male; Middle Aged; Penicillins; Piperacillin | 1991 |
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies | 1991 |
[Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mezlocillin; Middle Aged; Piperacillin; Sulbactam | 1991 |
Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Ceftazidime; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Superinfection | 1991 |
[Comparative study of 2 protocols for antibiotic therapy. Maternal-fetal non-specific bacterial infections during labor].
Topics: Amoxicillin; Apgar Score; Bacterial Infections; Birth Weight; Cesarean Section; Clinical Protocols; Female; Gestational Age; Humans; Infant, Newborn; Obstetric Labor Complications; Piperacillin; Pregnancy | 1990 |
[Antibiotic prophylaxis with piperacillin in vaginal hysterectomy. Study of 1 dose versus 3 doses].
Topics: Bacterial Infections; Drug Administration Schedule; Female; Humans; Hysterectomy; Piperacillin; Premedication; Prospective Studies; Surgical Wound Infection | 1990 |
[Evaluation of the effectiveness of sodium piperacillin in the treatment of surgical infections in children].
Topics: Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Piperacillin; Postoperative Complications | 1990 |
A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, Combination; Fever; Gentamicins; Glycopeptides; Hematologic Diseases; Humans; Neutropenia; Piperacillin; Prospective Studies; Teicoplanin | 1990 |
A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Injections, Intravenous; Middle Aged; Netilmicin; Neutropenia; Penicillin G; Piperacillin; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre Study.
Topics: Adolescent; Agranulocytosis; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Cloxacillin; Drug Therapy, Combination; Female; Fever; Finland; Floxacillin; Humans; Infant; Male; Neutropenia; Piperacillin; Random Allocation; Time Factors | 1990 |
Broad spectrum penicillin as an adequate therapy for acute cholangitis.
Topics: Acute Disease; Ampicillin; Bacterial Infections; Biliary Tract Neoplasms; Carcinoma; Cholangitis; Cholestasis; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperacillin; Prognosis; Prospective Studies; Recurrence; Tobramycin | 1990 |
Randomized trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis.
Topics: Amikacin; Ampicillin; Bacterial Infections; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Infant, Premature, Diseases; Piperacillin; Random Allocation; Risk Factors; Sepsis | 1989 |
Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients.
Topics: Adult; Agranulocytosis; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Infusions, Intravenous; Middle Aged; Netilmicin; Neutropenia; Penicillin G; Piperacillin; Random Allocation | 1989 |
Piperacillin for prophylaxis in gynecological surgery.
Topics: Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Hysterectomy; Intraoperative Period; Metronidazole; Piperacillin; Postoperative Complications; Premedication; Random Allocation; Time Factors | 1989 |
Single-dose piperacillin versus triple-dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy.
Topics: Adult; Bacterial Infections; Cefoxitin; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Length of Stay; Middle Aged; Piperacillin; Postoperative Complications; Premedication; Prospective Studies; Random Allocation | 1989 |
Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Intravenous; Injections, Intravenous; Leukemia; Lymphoma; Male; Middle Aged; Netilmicin; Neutropenia; Piperacillin; Prospective Studies; Random Allocation | 1989 |
A comparison of double beta-lactam combinations with netilmicin/ureidopenicillin regimens in the empirical therapy of febrile neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Microbial Sensitivity Tests; Netilmicin; Neutropenia; Penicillin G; Piperacillin; Random Allocation | 1989 |
Gentamicin and low dose piperacillin in febrile neutropenic patients.
Topics: Adult; Agranulocytosis; Bacterial Infections; Fever; Gentamicins; Humans; Injections, Intravenous; Leukemia; Leukocyte Count; Lymphoma; Neutropenia; Neutrophils; Piperacillin; Random Allocation | 1989 |
Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Female; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation | 1989 |
A multicentre study to compare piperacillin with the combination of netilmicin and metronidazole for prophylaxis in elective colorectal surgery undertaken in district general hospitals.
Topics: Adult; Aged; Bacterial Infections; Colon; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Netilmicin; Piperacillin; Postoperative Complications; Premedication; Rectum; Surgical Wound Infection | 1988 |
[Effectiveness and tolerance of piperacillin in 333 patients].
Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Respiratory Tract Infections; Urinary Tract Infections | 1986 |
[Treatment of infectious outbreaks in neutropenic patients with a piperacillin and amikacin combination].
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neutropenia; Pilot Projects; Piperacillin | 1986 |
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins | 1988 |
Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Mezlocillin; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Tobramycin | 1988 |
Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Piperacillin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Random Allocation | 1988 |
Ticarcillin plus clavulanic acid (Timentin) compared with standard antibiotic regimes in the treatment of early and late neonatal infections.
Topics: Bacterial Infections; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Floxacillin; Gentamicins; Humans; Infant, Newborn; Male; Penicillins; Piperacillin; Ticarcillin | 1988 |
Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies | 1988 |
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Vancomycin | 1988 |
Piperacillin and a combination of clindamycin and gentamicin for the treatment of hospital and community acquired acute pelvic infections including pelvic abscess.
Topics: Abscess; Adult; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Costs and Cost Analysis; Cross Infection; Drug Therapy, Combination; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Piperacillin; Random Allocation; Salpingitis | 1987 |
Antibiotics in infections of the biliary tract.
Topics: Ampicillin; Bacterial Infections; Cefoperazone; Cholangitis; Cholecystitis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Prospective Studies; Random Allocation; Tobramycin | 1987 |
A comparative trial of moxalactam plus ticarcillin and clavulanic acid or piperacillin as empiric antibiotic therapy for febrile cancer patients.
Topics: Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Piperacillin; Ticarcillin | 1987 |
Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
Topics: Adult; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Random Allocation | 1987 |
Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillin Resistance; Piperacillin; Prospective Studies; Random Allocation; Thienamycins | 1987 |
Piperacillin in prophylaxis and therapy of gynecologic cancer patients.
Topics: Bacterial Infections; Cefotetan; Cephalosporins; Clinical Trials as Topic; Female; Humans; Hysterectomy; Ovarian Neoplasms; Piperacillin; Placebos; Postoperative Complications; Random Allocation; Uterine Neoplasms | 1987 |
[Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefmenoxime; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies; Random Allocation | 1987 |
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation | 1986 |
A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillin Resistance; Penicillins; Piperacillin; Random Allocation; Sepsis; Ticarcillin; Tobramycin | 1986 |
A comparison of piperacillin and clindamycin plus gentamicin in women with pelvic infections.
Topics: Abortion, Septic; Abscess; Adolescent; Adult; Bacterial Infections; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Dilatation and Curettage; Drainage; Drug Therapy, Combination; Endometritis; Ethnicity; Female; Follow-Up Studies; Genital Diseases, Female; Gentamicins; Gonorrhea; Humans; Piperacillin; Pregnancy; Salpingitis | 1986 |
A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefoxitin; Cephalothin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Postoperative Complications; Premedication; Random Allocation | 1986 |
Clinical comparison of piperacillin and cefoxitin in patients with bacteriologically confirmed infections.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefoxitin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperacillin; Random Allocation | 1986 |
Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Clavulanic Acids; Cross Infection; Drug Combinations; Drug Evaluation; Female; Humans; Male; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Sepsis; Ticarcillin; Urinary Tract Infections | 1986 |
Intravenous ciprofloxacin in the treatment of infection in immunocompromised patients.
Topics: Adolescent; Adult; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Humans; Immune Tolerance; Infusions, Intravenous; Middle Aged; Netilmicin; Opportunistic Infections; Penicillin G; Piperacillin; Random Allocation | 1986 |
Role of piperacillin in surgical prophylaxis of genitourinary infections.
Topics: Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Female; Humans; Male; Piperacillin; Premedication; Surgical Wound Infection; Urinary Tract Infections; Urogenital System | 1985 |
A prospective double-blind comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing intra-abdominal operations.
Topics: Abdomen; Bacterial Infections; Cefoxitin; Cephalothin; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Piperacillin; Postoperative Complications; Preoperative Care; Surgical Wound Infection | 1985 |
A controlled study of ticarcillin plus clavulanic acid versus piperacillin as empiric therapy for fever in the immunocompromised host.
Topics: Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Fever; Humans; Immune Tolerance; Leukocyte Count; Neutrophils; Penicillins; Piperacillin; Ticarcillin | 1985 |
Comparative trial of ticarcillin plus clavulanic acid and piperacillin in the treatment of acute bacterial infection.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Penicillins; Piperacillin; Sepsis; Ticarcillin | 1985 |
Ceftazidime as first-line therapy for fever in acute leukaemia.
Topics: Adolescent; Adult; Bacterial Infections; Cefotaxime; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Netilmicin; Neutropenia; Penicillin Resistance; Piperacillin; Random Allocation; Sepsis | 1985 |
Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefoxitin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Gram-Negative Bacteria; Hospitalization; Humans; Male; Penicillins; Piperacillin; Respiratory Tract Infections; Sepsis; Ticarcillin; Tobramycin | 1985 |
Comparative study of ticarcillin plus clavulanate potassium versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Topics: Adult; Aged; Bacterial Infections; Child; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Hospitalization; Humans; Middle Aged; Penicillins; Piperacillin; Ticarcillin; Urinary Tract Infections | 1985 |
166 other study(ies) available for piperacillin and Bacterial Disease
| Article | Year |
|---|---|
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Enzyme Inhibitors; Humans; Lactams; Microbial Sensitivity Tests; Piperacillin | 2009 |
Efficacy of piperacillin combined with the Penem beta-lactamase inhibitor BLI-489 in murine models of systemic infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Female; Lactams; Mice; Piperacillin | 2009 |
Clinico-microbiological profile of
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Chloramphenicol; Clindamycin; Drug Resistance, Bacterial; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 2021 |
Ultrasound-responsive catalytic microbubbles enhance biofilm elimination and immune activation to treat chronic lung infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Biofilms; Lung; Mice; Microbubbles; Piperacillin; Pseudomonas aeruginosa | 2023 |
Dose optimization of piperacillin/tazobactam in critically ill children.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Tazobactam | 2017 |
Hospital Length of Stay Among Patients Receiving Intermittent Versus Prolonged Piperacillin/Tazobactam Infusion in the Intensive Care Units.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Female; Hospital Mortality; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2018 |
Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Creatinine; Febrile Neutropenia; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2017 |
Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clostridium Infections; Cohort Studies; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Floxacillin; Humans; Incidence; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurotoxicity Syndromes; Piperacillin; Retrospective Studies; Thienamycins | 2017 |
Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Bacterial Infections; beta-Lactams; Cefotaxime; Drug Monitoring; Female; Humans; Length of Stay; Male; Meropenem; Patient Readmission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Sweden; Thienamycins | 2018 |
Gram negative anaerobe susceptibility testing in clinical isolates using Sensititre and Etest methods.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2018 |
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins | 2016 |
Reduced VRE and MRSA colonisation and infection following sustained reduction in broad spectrum antibiotic use in a large tertiary hospital.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Utilization Review; Humans; Methicillin-Resistant Staphylococcus aureus; New South Wales; Piperacillin; Tazobactam; Vancomycin-Resistant Enterococci | 2019 |
Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2019 |
Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Body Weight; Child; Child, Preschool; Female; Fever; Glomerular Filtration Rate; Humans; Infant; Male; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2019 |
Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Drug Monitoring; Female; Humans; Male; Meropenem; Middle Aged; Piperacillin; Protein Binding; Young Adult | 2020 |
Reply to Soman et al and Frippiat et al.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis | 2013 |
Are prolonged/continuous infusions of β-lactams for all?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis | 2013 |
Is extended or continuous infusion of carbapenems the obvious solution to improve clinical outcomes and reduce mortality?
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Humans; Penicillanic Acid; Piperacillin | 2013 |
The Pediatric Infectious Disease Journal® newsletter.
Topics: Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Colistin; Humans; Infant; Infant, Newborn; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Public Health Administration; Virus Diseases | 2013 |
Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-P) for treatment of infected patients at Siriraj Hospital.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Child; Drugs, Generic; Female; Hospitals; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thailand; Young Adult | 2013 |
Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Drug Combinations; Drug Stability; Humans; Infusions, Intravenous; Isotonic Solutions; Nephelometry and Turbidimetry; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Vancomycin | 2013 |
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins | 2013 |
Population pharmacokinetics of piperacillin/tazobactam in critically ill young children.
Topics: Bacterial Infections; Child; Child, Preschool; Cohort Studies; Critical Illness; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Monte Carlo Method; Penicillanic Acid; Philadelphia; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2014 |
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole | 2014 |
Population pharmacokinetic analysis of piperacillin in burn patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Burns; Computer Simulation; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult | 2014 |
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Creatinine; Critical Illness; Drug Dosage Calculations; Drug Therapy, Computer-Assisted; Female; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precision Medicine; Pseudomonas aeruginosa; Young Adult | 2014 |
Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacterial Infections; Female; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intestines; Liver Transplantation; Male; Middle Aged; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prospective Studies | 2014 |
Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Enterobacter cloacae; Humans; Mesothelin; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam | 2015 |
Epidemiology of antimicrobial resistance in an oncology center in eastern India.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts | 2015 |
Top Guns: The "Maverick" and "Goose" of Empiric Therapy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency; Retrospective Studies; Risk Assessment; Vancomycin | 2016 |
Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Dialysis Solutions; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors | 2016 |
Piperacillin-Tazobactam-induced Adverse Drug Events in Pediatric Patients on Outpatient Parenteral Antimicrobial Therapy.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Female; Humans; Infant; Infusions, Parenteral; Kaplan-Meier Estimate; Male; Outpatients; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2017 |
[Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis].
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Candidiasis; Catheters; Diarrhea; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mycoses; Penicillanic Acid; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Recurrence; Retrospective Studies; Staphylococcus epidermidis; Staphylococcus haemolyticus; Vomiting | 2016 |
Broad-spectrum antibiotics in Norwegian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization Review; Guideline Adherence; Hospitals; Humans; Norway; Piperacillin; Quinolones; Respiratory Tract Infections | 2017 |
Piperacillin-tazobactam penetration into human pancreatic juice.
Topics: Aged; Ampulla of Vater; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Common Bile Duct Neoplasms; Female; Humans; Male; Middle Aged; Pancreatic Diseases; Pancreatic Juice; Pancreatic Neoplasms; Pancreaticoduodenectomy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2008 |
Diabetic foot ulcer: assessment and management.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Humans; Piperacillin | 2008 |
Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Italy; Male; Middle Aged; Outpatient Clinics, Hospital; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Staphylococcal Infections; Young Adult | 2008 |
Pylephlebitis after a duodenal ulcer in a patient with metastasised colon carcinoma treated with chemotherapy and bevacizumab: a case report.
Topics: Aged; Amoxicillin; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bacterial Infections; Bevacizumab; Clavulanic Acid; Colorectal Neoplasms; Duodenal Ulcer; Humans; Male; Penicillanic Acid; Piperacillin; Portal Vein; Tazobactam; Thrombophlebitis | 2009 |
Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cost-Benefit Analysis; Decision Trees; Diabetic Foot; Direct Service Costs; Drug Costs; Drug Resistance, Bacterial; Ertapenem; Humans; Models, Biological; Models, Econometric; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom | 2009 |
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Piperacillin; Plasma; Sepsis; Young Adult | 2010 |
Daily serum piperacillin monitoring is advisable in critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug Monitoring; Female; France; Hospitals, Teaching; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Serum; Tazobactam; Time Factors | 2010 |
Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia.
Topics: Acute Lung Injury; Anemia, Aplastic; Animals; Anti-Bacterial Agents; Antilymphocyte Serum; Bacterial Infections; Bone Marrow Transplantation; Child; Cyclophosphamide; Horses; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Transplantation Conditioning; Vancomycin; Vidarabine | 2011 |
Analysis of isolated bacteria and short-term antimicrobial prophylaxis with tazobactam-piperacillin (1:4 ratio) for prevention of postoperative infections after radical cystectomy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Bacterial Infections; Cystectomy; Female; Humans; Japan; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surgical Wound Infection; Treatment Outcome; Urinary Tract Infections | 2012 |
Dosing of piperacillin/tazobactam in a morbidly obese patient.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Male; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Serum | 2012 |
Microbiological and clinical characteristics of diabetic foot infections in northern India.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Diabetic Foot; Female; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies | 2012 |
Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Bacterial Infections; Ceftazidime; Drug Resistance, Bacterial; Escherichia coli; Fever; Gram-Positive Bacteria; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Israel; Meropenem; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins; Treatment Outcome; Young Adult | 2012 |
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult | 2013 |
Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/tazobactam in patients undergoing hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Bacterial Infections; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Penicillanic Acid; Pilot Projects; Piperacillin; Tazobactam; Transplantation, Autologous; Transplantation, Homologous | 2002 |
In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes | 2002 |
[A questionnaire survey on the theory of postoperative infection prophylaxis in urology].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cefazolin; Cefotiam; Humans; Penicillins; Piperacillin; Postoperative Complications; Surgical Wound Infection; Surveys and Questionnaires; Urology | 2002 |
[Outpatient parenteral antibiotic therapy (OPAT) of diabetic foot infections with piperacillin/tazobactam].
Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Injections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2002 |
In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles.
Topics: Bacteria; Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacteria; Humans; In Vitro Techniques; Ireland; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; United Kingdom | 2003 |
Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient.
Topics: Anti-Bacterial Agents; Bacterial Infections; Confusion; Delirium; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Hallucinations; Humans; Kidney Failure, Chronic; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Tazobactam | 2004 |
Relationship between pharmacokinetics and pharmacodynamics of beta-lactams and outcome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftriaxone; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Treatment Outcome | 2004 |
In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors.
Topics: Animals; Area Under Curve; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Bridged Bicyclo Compounds; Crystallography, X-Ray; Enzyme Inhibitors; Female; Heterocyclic Compounds; Kinetics; Mice; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rats; Rats, Wistar; Structure-Activity Relationship | 2004 |
Antimicrobial susceptibility of aerobic microorganisms isolated from intraabdominal infections in pediatric patients in Poland.
Topics: Abdomen; Adolescent; Bacteria, Aerobic; Bacterial Infections; beta-Lactamases; Child; Child, Preschool; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Infant; Infant, Newborn; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poland; Pseudomonas aeruginosa | 2005 |
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolines | 2005 |
In vitro study of the antibacterial activity of cefotetan compared with piperacillin and ceftriaxone against bacterial strains isolated from pathological material of hospital patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotetan; Ceftriaxone; Humans; Inpatients; Microbial Sensitivity Tests; Piperacillin | 1989 |
Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gastric Juice; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Swine; Tazobactam | 1989 |
Piperacillin vs gentamicin-clindamycin combination in intra-abdominal infections.
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Piperacillin | 1989 |
Single-dose prophylaxis in elective colorectal surgery: a prospective, randomized trial with piperacillin or latamoxef.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Colonic Diseases; Elective Surgical Procedures; Humans; Moxalactam; Piperacillin; Rectal Diseases; Surgical Wound Infection | 1989 |
Piperacillin in antibiotic prophylaxis for gynecological surgery.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Drug Administration Schedule; Female; Gynecologic Surgical Procedures; Humans; Piperacillin; Postoperative Complications; Surgical Wound Infection | 1989 |
Piperacillin: as a single-dose prophylactic agent in hysterectomies.
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Female; Humans; Hysterectomy; Metronidazole; Piperacillin; Surgical Wound Infection | 1989 |
Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Population Surveillance; Prevalence; Soft Tissue Infections; Thienamycins | 2005 |
In-vitro evaluation of "piperacillin and tazobactum" combination in a tertiary-care hospital--a preliminary study.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 2006 |
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Escherichia coli; Female; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Time Factors; Treatment Outcome; Urinary Tract Infections | 2006 |
Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Colon; False Positive Reactions; Female; Galactose; Gastrectomy; Humans; Kinetics; Male; Mannans; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rectum | 2006 |
Influence of culture site-specific MIC distributions on the pharmacokinetic and pharmacodynamic properties of piperacillin/tazobactam and piperacillin: a data analysis.
Topics: Anti-Bacterial Agents; Bacterial Infections; Data Interpretation, Statistical; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2006 |
Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; beta-Lactams; Ceftazidime; Ceftriaxone; Digestive System Diseases; Enterobacter cloacae; Enterococcus faecalis; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus mirabilis; Staphylococcus aureus; Time Factors | 2006 |
Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Fosfomycin; Glycopeptides; Humans; Infant; Length of Stay; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Teicoplanin; Treatment Outcome | 2006 |
Experience with the use of piperacillin-tazobactam in pediatric non-renal solid organ transplantation.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Mycoses; Organ Transplantation; Penicillanic Acid; Piperacillin; Tazobactam | 2007 |
Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Ertapenem; Female; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Treatment Failure | 2007 |
Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia.
Topics: Abdomen; Anti-Infective Agents; Asia; Bacterial Infections; beta-Lactamase Inhibitors; Consensus; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic | 2007 |
Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Drug Administration Schedule; Drug Combinations; Ertapenem; Female; Health Care Costs; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2007 |
Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Burns; Cephalothin; Debridement; Drug Administration Schedule; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam | 2007 |
Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey.
Topics: Bacterial Infections; Fever of Unknown Origin; Humans; Hypersensitivity; Infant; Infant, Newborn; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Withholding Treatment | 2007 |
Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newborns.
Topics: Anti-Bacterial Agents; Bacterial Infections; Birth Weight; Drug Monitoring; Drug Therapy, Combination; Female; Gentamicins; Gestational Age; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Piperacillin; Sepsis | 2007 |
Activities of two aminoglycosides and five newer beta-lactam antibiotics: safer alternatives to aminoglycosides?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftazidime; Humans; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Tobramycin | 1984 |
Clinical and microbiological evaluation of piperacillin in elective biliary surgery.
Topics: Bacteria; Bacterial Infections; Bile; Biliary Tract Diseases; Biological Availability; Common Bile Duct; Gallbladder; Humans; Intraoperative Care; Piperacillin; Preoperative Care; Surgical Wound Infection | 1983 |
Piperacillin sodium (Pipracil).
Topics: Bacteria; Bacterial Infections; Humans; Penicillins; Piperacillin | 1982 |
[Update on antibiotic therapy. 5) Piperacillin].
Topics: Bacteria; Bacterial Infections; Humans; Kinetics; Penicillins; Piperacillin | 1982 |
Clinical evaluation of the therapeutic efficacy and tolerability of piperacillin.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Carbenicillin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Piperacillin; Pseudomonas; Time Factors | 1982 |
Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
Topics: Amikacin; Azlocillin; Bacterial Infections; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Piperacillin | 1982 |
Sepsis associated with urinary tract infection. Antibiotic treatment with piperacillin.
Topics: Adult; Bacterial Infections; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Penicillins; Piperacillin; Pseudomonas Infections; Shock, Septic; Urinary Tract Infections | 1982 |
The penicillins.
Topics: Amoxicillin; Ampicillin; Bacterial Infections; Carbenicillin; Drug Administration Schedule; Drug Evaluation; Drug Hypersensitivity; Drug Synergism; Humans; Penicillin G; Penicillins; Piperacillin; Probenecid; Ticarcillin | 1983 |
Pharmacokinetics of intravenously administered piperacillin in preadolescent children.
Topics: Bacterial Infections; Child; Child, Preschool; Half-Life; Humans; Infant; Infusions, Parenteral; Metabolic Clearance Rate; Penicillins; Piperacillin | 1983 |
[Bacteriological and clinical evaluation of piperacillin in the field of obstetrics and gynecology].
Topics: Adult; Bacterial Infections; Escherichia coli; Female; Genital Diseases, Female; Humans; Pelvic Inflammatory Disease; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas | 1982 |
[Antibacterial activity of the combination of cefoperazone piperacillin].
Topics: Bacteria; Bacterial Infections; Cefoperazone; Cephalosporins; Drug Combinations; Humans; Penicillins; Piperacillin | 1983 |
Clinical evaluation of combination of cefmetazole and piperacillin in the treatment of infections in patients with acute leukemia.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Cefmetazole; Cephalosporins; Cephamycins; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Penicillins; Piperacillin | 1983 |
[Penetration of piperacillin into the cerebrospinal fluid of patients with purulent meningitis].
Topics: Adolescent; Adult; Aged; Ampicillin; Bacterial Infections; Chromatography, High Pressure Liquid; Diffusion; Female; Gram-Negative Bacteria; Humans; Male; Meningitis; Middle Aged; Piperacillin | 1984 |
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Humans; Imipenem; Lactams; Penicillins; Piperacillin; Species Specificity | 1981 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas; Quinolines; Staphylococcus; Tobramycin | 1984 |
Intra-abdominal infection: microbiological and clinical aspects, with special reference to piperacillin prophylaxis and therapy.
Topics: Abscess; Animals; Bacterial Infections; Bacteriological Techniques; Biliary Tract Surgical Procedures; Digestive System; Digestive System Surgical Procedures; Disease Models, Animal; Drainage; Humans; Peritonitis; Piperacillin; Premedication; Rats; Surgical Wound Infection | 1984 |
In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
Topics: Ampicillin; Azlocillin; Bacteria; Bacterial Infections; Enterobacteriaceae; Humans; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin; Ticarcillin | 1980 |
Piperacillin therapy for serious bacterial infections.
Topics: Adult; Aged; Bacterial Infections; Diarrhea; Drug Evaluation; Drug Hypersensitivity; Female; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1980 |
In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cephalosporins; Drug Interactions; Male; Mezlocillin; Mice; Penicillins; Piperacillin | 1981 |
Piperacillin Sodium (a phase III clinical trial).
Topics: Adolescent; Adult; Aged; Bacterial Infections; Child; Female; Humans; Injections, Intravenous; Male; Middle Aged; Penicillins; Piperacillin | 1981 |
Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Anti-Bacterial Agents; Bacterial Infections; Cefmetazole; Cephalosporins; Cephamycins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutrophils; Penicillins; Piperacillin; Tobramycin | 1981 |
From penicillin to piperacillin. Proceedings of a symposium, 15 October 1981.
Topics: Bacterial Infections; Humans; Penicillins; Piperacillin | 1982 |
Comparative activity in vitro of piperacillin.
Topics: Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Stability; Drug Synergism; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; R Factors | 1982 |
Piperacillin against clinical isolates: antimicrobial profile and clinical role.
Topics: Bacteria; Bacterial Infections; Escherichia coli; Humans; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin | 1982 |
Susceptibility patterns of bacteria following therapy with piperacillin.
Topics: Bacteria; Bacterial Infections; Carbenicillin; Humans; Penicillin Resistance; Penicillins; Piperacillin | 1982 |
Piperacillin: a review of clinical experience.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Carbenicillin; Female; Humans; Male; Middle Aged; Penicillins; Piperacillin | 1982 |
[Chemotherapy of biliary tract infections. XIV. Biliary excretion and gallbladder tissue levels of piperacillin (author's transl)].
Topics: Adult; Aged; Ampicillin; Bacterial Infections; Bile; Biliary Tract Diseases; Female; Gallbladder; Humans; Injections, Intravenous; Male; Middle Aged; Naphthyridines; Penicillins; Piperacillin; Ticarcillin; Trace Elements | 1981 |
In vitro microbiology and pharmacokinetics of piperacillin.
Topics: Adult; Bacterial Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Peritonitis; Piperacillin | 1984 |
[Chemotherapy of biliary tract infections (XXIV). Biliary excretion and gallbladder tissue levels of mezlocillin].
Topics: Adult; Aged; Bacterial Infections; Bile; Biliary Tract Diseases; Female; Gallbladder; Humans; Injections, Intravenous; Male; Mezlocillin; Middle Aged; Piperacillin | 1984 |
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacteria, Anaerobic; Bacterial Infections; Child; Drug Evaluation; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Fever; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Piperacillin; Pseudomonas Infections; Random Allocation; Staphylococcal Infections | 1984 |
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.
Topics: Bacterial Infections; Drug Combinations; Fever; Humans; Leukocyte Count; Neoplasms; Neutrophils; Piperacillin; Sepsis; Vancomycin | 1984 |
[Piperacillin].
Topics: Bacterial Infections; Drug Interactions; Humans; Kinetics; Piperacillin | 1984 |
Piperacillin in early neonatal infection.
Topics: Bacterial Infections; Drug Therapy, Combination; Floxacillin; Gentamicins; Gram-Negative Bacteria; Humans; Infant, Newborn; Infant, Premature, Diseases; Kinetics; Meningitis; Penicillin Resistance; Penicillins; Piperacillin | 1983 |
Directed and non-directed treatment of abdominal infections.
Topics: Abdomen; Anti-Bacterial Agents; Azlocillin; Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Peritonitis; Piperacillin | 1984 |
In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers.
Topics: Ampicillin; Bacterial Infections; Carbenicillin; Enterobacteriaceae; Gram-Negative Anaerobic Bacteria; Humans; Naphthyridines; Piperacillin; Pseudomonas; Streptococcus | 1984 |
Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
Topics: Abdomen; Animals; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Gentamicins; Imipenem; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam | 1994 |
[Drugs: piperacillin/tazobactam].
Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Humans; Penicillanic Acid; Piperacillin; Tazobactam | 1995 |
The activity of piperacillin/tazobactam against clinical isolates collected in 20 UK centres and the design of a disc test for susceptibility testing.
Topics: Bacteria, Aerobic; Bacterial Infections; beta-Lactamase Inhibitors; Culture Media; Diffusion; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam; United Kingdom | 1993 |
Piperacillin/tazobactam.
Topics: Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1994 |
Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Units; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Prevalence | 1993 |
Therapy of soft tissue infections with piperacillin/tazobactam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Risk Factors; Skin Diseases, Infectious; Tazobactam | 1993 |
Susceptibility survey of piperacillin alone and in the presence of tazobactam.
Topics: Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1993 |
[Severe diffuse facial cellulitis].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Bacterial Infections; Cause of Death; Cellulitis; Child; Drug Therapy, Combination; Face; Female; Forecasting; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Neck; Penicillins; Piperacillin; Premedication; Risk Factors; Treatment Outcome | 1997 |
Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aztreonam; Bacterial Infections; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Etoposide; Female; Fever; Fluorouracil; Genital Neoplasms, Female; Humans; Injections, Intravenous; Middle Aged; Monobactams; Neutropenia; Penicillins; Piperacillin; Retrospective Studies; Treatment Outcome; Urine | 1998 |
Management of small infected tibial defects with antibiotic-impregnated autogenic cancellous bone grafting.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Bone Transplantation; Chronic Disease; Debridement; Drug Carriers; Female; Fractures, Ununited; Humans; Male; Middle Aged; Osteomyelitis; Piperacillin; Polymethyl Methacrylate; Tibial Fractures; Transplantation, Autologous; Vancomycin | 1998 |
Suspected infection in children with cancer.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Bacteriuria; Catheterization, Central Venous; Child; Child, Preschool; Clinical Protocols; Drug Resistance, Microbial; Feces; Fever; Floxacillin; Gram-Positive Bacterial Infections; Hospitals, Pediatric; Humans; Infant; Leukocyte Count; Methicillin Resistance; Neoplasms; Neutrophils; Penicillin Resistance; Penicillins; Piperacillin; Pulse; Retrospective Studies; Skin; Staphylococcal Infections; Tobramycin | 1998 |
In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
Topics: Bacteria; Bacterial Infections; beta-Lactams; Brazil; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Hospitals, University; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2000 |
Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.
Topics: Abdomen; Adult; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cost-Benefit Analysis; Decision Trees; Drug Combinations; Drug Costs; Drug Therapy, Combination; Health Care Costs; Humans; Imipenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protease Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Thienamycins | 2001 |
Effect of pH on antibiotics used to treat anaerobic infection.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cefoxitin; Clindamycin; Drug Therapy, Combination; Hydrogen-Ion Concentration; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam | 1992 |
Effect of piperacillin/tazobactam therapy on intestinal microflora.
Topics: Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Feces; Female; Humans; Intestines; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Yeasts | 1992 |
[Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Pefloxacin; Piperacillin; Prospective Studies; Renal Insufficiency; Vancomycin | 1992 |
Gingival status during chemical plaque control with or without prior mechanical plaque removal in patients with acute myeloid leukaemia.
Topics: Aclarubicin; Acute Disease; Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Chlorhexidine; Cytarabine; Dental Calculus; Dental Plaque; Dental Scaling; Female; Gingival Hemorrhage; Gingivitis; Humans; Leukemia, Myeloid; Leukopenia; Male; Middle Aged; Mouthwashes; Netilmicin; Piperacillin; Premedication; Thrombocytopenia | 1992 |
Pharmacokinetic study of piperacillin in newborns relating to gestational and postnatal age.
Topics: Bacterial Infections; Birth Weight; Female; Gestational Age; Humans; Infant, Newborn; Male; Piperacillin | 1992 |
Piperacillin/tazobactam in the treatment of serious acute soft tissue infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam | 1991 |
[Treatment of severe infections in hematologic malignancies with piperacillin sodium].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Bacterial Infections; Bone Marrow Diseases; Cephalosporins; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Piperacillin; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
Topics: Amikacin; Animals; Bacterial Infections; Bacteroides fragilis; Carbapenems; Ceftazidime; Cilastatin; Ciprofloxacin; Dipeptidases; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Klebsiella pneumoniae; Metronidazole; Mice; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins | 1991 |
Sulbactam/ampicillin combination in the treatment of acute and chronic lower respiratory infections.
Topics: Adolescent; Adult; Aged; Ampicillin; Bacterial Infections; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperacillin; Respiratory Tract Infections; Sulbactam | 1991 |
[Therapy of bacterial pharyngo-tonsillitis in children with piperacillin-flucloxacillin combination].
Topics: Bacterial Infections; Child; Child, Preschool; Cloxacillin; Drug Combinations; Drug Evaluation; Female; Floxacillin; Humans; Infant; Male; Pharyngitis; Piperacillin; Time Factors; Tonsillitis | 1990 |
[The results of antibiotic therapy in acute severe pneumonia dependent on the initial severity].
Topics: Acute Disease; Amikacin; Bacterial Infections; Drug Combinations; Female; Humans; Male; Middle Aged; Piperacillin; Pneumonia; Prognosis | 1990 |
[Short-term antibiotic prophylaxis in surgery. Our experience with the use of piperacillin in 261 patients].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Injections, Intramuscular; Male; Piperacillin; Postoperative Complications; Preanesthetic Medication | 1990 |
[Empirical treatment of febrile episodes in granulocytopenic patients with a combination of piperacillin and ofloxacin. Preliminary study].
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies | 1990 |
[Piperacillin in the therapy of severe bacterial infections: comparison of its efficacy and tolerance vs. ceftazidime].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Ceftazidime; Drug Evaluation; Drug Tolerance; Humans; Infant; Injections, Intravenous; Male; Middle Aged; Piperacillin | 1989 |
Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 1989 |
[Piperacillin: a choice position].
Topics: Bacterial Infections; Humans; Piperacillin | 1986 |
[Piperacillin in in vitro-in vivo combination].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Humans; Penicillin Resistance; Piperacillin | 1986 |
[Indications for piperacillin in pediatrics].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Female; Gram-Negative Bacteria; Humans; Infant; Male; Piperacillin; Retrospective Studies | 1986 |
[Piperacillin in the newborn infant. A clinical and pharmacologic study].
Topics: Bacterial Infections; Humans; Infant, Newborn; Kinetics; Penicillin Resistance; Piperacillin | 1986 |
[Piperacillin combined with netilmicin and cloxacillin. Usefulness in the treatment of febrile episodes in neutropenic children].
Topics: Adolescent; Adult; Agranulocytosis; Bacterial Infections; Child; Child, Preschool; Cloxacillin; Drug Therapy, Combination; Fever; Humans; Netilmicin; Neutropenia; Piperacillin | 1986 |
[Faulty use of antibiotics and the development of resistance].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Humans; Mezlocillin; Piperacillin; Risk Factors | 1988 |
[Treatment with a piperacillin and netilmicin combination of patients with agranulocytosis].
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; Piperacillin; Sepsis | 1988 |
[Efficacy of the piperacillin-aztreonam combination in antibiotic prophylaxis during the neonatal period].
Topics: Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Piperacillin; Risk Factors | 1988 |
Use of a continuous culture system for susceptibility testing of gram-negative bacterial isolates to piperacillin.
Topics: Bacterial Infections; Culture Media; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Piperacillin; Time Factors | 1988 |
[Empiric therapy with piperacillin plus amikacin in febrile granulocytopenic patients with acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blast Crisis; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Male; Middle Aged; Piperacillin | 1986 |
Effect of piperacillin on some cellular and humoral factors of the immune system.
Topics: Antibodies; Antibody Formation; Bacterial Infections; Humans; Immunity, Cellular; Piperacillin; Rosette Formation | 1987 |
[Effectiveness of various immunoglobulin preparations administered by the intravenous route in peritonitis in the rat model].
Topics: Animals; Bacterial Infections; Combined Modality Therapy; Gentamicins; Immunoglobulin G; Infusions, Intravenous; Infusions, Parenteral; Peritonitis; Piperacillin; Rats | 1987 |
Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.
Topics: Adolescent; Agranulocytosis; Bacterial Infections; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Gentamicins; Humans; Neoplasms; Neutropenia; Piperacillin; Prospective Studies | 1987 |
Treatment and prevention of female pelvic infection: the quest for single-agent therapy.
Topics: Anti-Bacterial Agents; Bacterial Infections; Female; Humans; Pelvic Inflammatory Disease; Piperacillin; Premedication; Surgical Wound Infection | 1987 |
[Fundamental study of piperacillin sodium in term and premature neonates].
Topics: Acute Disease; Bacterial Infections; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Male; Piperacillin; Pneumonia | 1987 |
Nonfatal chromobacterial sepsis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Chromobacterium; Drug Therapy, Combination; Humans; Liver Abscess; Male; Piperacillin; Tobramycin | 1986 |
Piperacillin activity and anaerobic infections.
Topics: Bacteria, Anaerobic; Bacterial Infections; Humans; Penicillin Resistance; Piperacillin | 1985 |
A survey of temocillin sensitivity of strains resistant to newer beta-lactam antibiotics.
Topics: Bacterial Infections; Cefotaxime; Humans; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1985 |
[Bronchial diffusion of piperacillin in 18 intensive care patients].
Topics: Bacterial Infections; Bronchi; Bronchial Diseases; Haemophilus Infections; Haemophilus influenzae; Humans; Piperacillin; Pneumococcal Infections; Pneumonia | 1985 |
The new penicillins.
Topics: Ampicillin; Azlocillin; Bacteria; Bacterial Infections; Humans; Mezlocillin; Piperacillin | 1985 |
Developmental pharmacology and therapeutics of piperacillin in gram-negative infections.
Topics: Adolescent; Adult; Aging; Bacterial Infections; Child; Child, Preschool; Female; Gram-Negative Bacteria; Humans; Infant; Kinetics; Male; Models, Biological; Piperacillin; Urinary Tract Infections | 1986 |
[A study on administration of antibiotics during operation for prevention of postoperative infections].
Topics: Adult; Bacterial Infections; Cefoperazone; Child; Cysteine; Humans; Intraoperative Period; Piperacillin; Surgical Wound Infection; Tiopronin | 1985 |
[Empiric therapy with piperacillin plus amikacin for febrile patients with cancer--with emphasis on granulocytopenia].
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kanamycin; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neoplasms; Piperacillin | 1985 |
[Cefoperazone: microbiological, kinetic and clinical studies].
Topics: Bacterial Infections; Bronchitis; Cefoperazone; Erysipelas; Humans; Kinetics; Mezlocillin; Piperacillin; Tonsillitis; Urinary Tract Infections | 1985 |
Piperacillin versus clindamycin plus gentamicin.
Topics: Bacterial Infections; Clindamycin; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Piperacillin | 1985 |